PDCD1 and cancer: It was found that HLA-E was more frequently expressed than PD-L1 in several types of cancer, including Merkel cell carcinoma, and, additionally, the in vivo CRISPR screening knock-out of Qa1b led to the increased efficacy of immunotherapy by PD-1 blockade.